Call for evidence: An inquiry into the links between antibiotic resistance & lack of access to clean water, hygiene & sanitation facilities, in healthcare settings across the world’s least developed countries

The All-Party Parliamentary Groups on Antibiotics, and Water, Sanitation and Hygiene, are staging a joint inquiry into the links between antibiotic resistance and lack of access to clean water, hygiene and sanitation facilities in healthcare settings across the least developed countries of the world. Antibiotic resistance is now a leading cause of death worldwide (contributing […]

Read More… from Call for evidence: An inquiry into the links between antibiotic resistance & lack of access to clean water, hygiene & sanitation facilities, in healthcare settings across the world’s least developed countries

Lord Trees calls for the Environment Bill to address AMR surveillance

The Treasurer of the APPG on Antibiotics, Lord Trees, has argued that the Environment Bill – which has just received its 2nd Reading in the House of Lords – must consider addressing the existential threat of antimicrobial resistance (AMR). Specifically, he called for the Bill to commit UK Government to the mandatory routine surveillance of […]

Read More… from Lord Trees calls for the Environment Bill to address AMR surveillance

Joint APPG letter to the Prime Minister on the G7 and aid cuts

The APPG on Antibiotics has joined 11 other APPGs to write a letter to the Prime Minister Boris Johnson, ahead of the G7 Leaders’ Summit, to highlight the need for UK leadership to ensure a bold and ambitious policy agenda that puts people and planet at the centre of the world’s recovery from the Covid-19 […]

Read More… from Joint APPG letter to the Prime Minister on the G7 and aid cuts

A letter to the Prime Minister

The Chair of the APPG on Antibiotics, Julian Sturdy MP, has written to the Prime Minister asking him to consider appointing a Minister with a specific portfolio to address both drug-resistant infection and pandemic prevention and preparedness. The letter has been co-signed by 35 Parliamentarians, including several former Ministers. Letter to PM on drug-resistant infections […]

Read More… from A letter to the Prime Minister

Special issue: WHO Global Action Plan on Antimicrobial Resistance newsletter

Following the recent high-level meeting on antimicrobial resistance at the UN General Assembly on 21st September 2016, WHO have provided this Special Issue of the WHO Global Action Plan on Antimicrobial Resistance newsletter. This newsletter will provide you with an update of the high-level meeting itself as well as feedback on some of the many […]

Read More… from Special issue: WHO Global Action Plan on Antimicrobial Resistance newsletter

Antibiotic Action & BSAC Respond to UN Declaration on Drug-Resistant Infections

BSAC applauds and welcomes signing, by all 193 countries of the United Nations, of a landmark declaration to rid the world of drug-resistant infections or “superbugs”, a declaration that has the potential to prevent 700,000 deaths a year according to expert estimates. Professor Dilip Nathwani OBE, President of BSAC and Consultant Physician and Honorary Professor […]

Read More… from Antibiotic Action & BSAC Respond to UN Declaration on Drug-Resistant Infections

FULL REPORT: Non-medical uses of antibacterial compounds (antibiotics): time to restrict their use?

The latest report of the All-Party Parliamentary Group on Antibioitcs ‘Non-medical uses of antibacterial compounds (antibiotics): time to restrict their use?‘ highlights the use of antibiotics outside of human medicine and the need to restrict this practice to delay the selection and spread of antibiotic resistant bacteria. […]

Read More… from FULL REPORT: Non-medical uses of antibacterial compounds (antibiotics): time to restrict their use?

Antibiotics: the changing regulatory and pharmaceutical – publication

Antibiotics: the changing regulatory and pharmaceutical – published Journal of Antimicrobial Chemotherapy, January 2015 Abstract: Drug licensing is changing. Previously, regulators prioritized the licensing of innovative drugs that fulfilled a high unmet medical need for a small number of patients, including orphan, cancer and HIV medicines. Alternatives to large and costly prospective, randomized, double-blind clinical […]

Read More… from Antibiotics: the changing regulatory and pharmaceutical – publication

APPG-A report on NON-HUMAN USES OF ANTIBIOTICS: TIME TO RESTRICT THEIR USE?

The global crisis of antibiotic resistance has reached a point where, if action is not taken, human medicine will enter a post-antibiotic world.  The extensive use of antibiotics outside clinical settings is often overlooked.  Given the current crisis, it is vital that the non-medical use of antibiotics is critically examined and that any non-essential use […]

Read More… from APPG-A report on NON-HUMAN USES OF ANTIBIOTICS: TIME TO RESTRICT THEIR USE?